Literature DB >> 23821183

The trigger-maintenance model of persistent mild to moderate hyperoxaluria induces oxalate accumulation in non-renal tissues.

Susan Ruth Marengo1, Brian S Zeise, Christopher G Wilson, Gregory T MacLennan, Andrea M P Romani.   

Abstract

Persistent mild to moderate hyperoxaluria (PMMH) is a common side effect of bariatric surgery. However, PMMH's role in the progression to calcium oxalate (CaOx) urolithiasis and its potential effects on non-renal tissues are unknown. To address these points, a trigger + maintenance (T + Mt) model of PMMH was developed in rats (Experiment 1). The trigger was an i.p. injection of PBS (TPBS) or 288 μmol sodium oxalate (T288). Maintenance (Mt) was given via minipumps dispensing PBS or 7.5-30 μmol potassium oxalate/day for 28 days. Urinary oxalate ranged from 7.7 ± 0.8 μmol/day for TPBS + MtPBS to 18.2 ± 1.5 μmol/day for T288 + Mt30 (p ≤ 0.0005). All rats receiving T288 developed CaOx nephrocalcinosis, and many developed 'stones'. This was also true for Mt doses that did not elevate urinary oxalate above that of TPBS + MtPBS (p > 0.1) and for rats that did not have a detectable surge in urinary oxalate post T288. When TPBS was administered, CaOx nephrocalcinosis did not develop regardless of the Mt dose even if urinary oxalate was elevated compared to TPBS + MtPBS (p ≤ 0.0005). One of the risks associated with PMMH is oxalate accumulation within tissues. Hence, in a second set of experiments (Experiment 2) different doses of oxalate (Mt0.05, Mt15, Mt30) labeled with (14)C-oxalate ((14)C-Ox) were administered by minipump for 13 days. Tissues were harvested and (14)C-Ox accumulation assessed by scintillation counting. (14)C-Ox accumulated in a dose dependent manner (p ≤ 0.004) in bone, kidney, muscle, liver, heart, kidney, lungs, spleen, and testis. All these tissues exhibited (14)C-Ox concentrations higher (p ≤ 0.05) than the plasma. Extrapolation of our results to patients suggests that PMMH patients should take extra care to avoid dietary-induced spikes in oxalate excretion to help prevent CaOx nephrocalcinosis or stone development. Monitoring for oxalate accumulation within tissues susceptible to damage by oxalate or CaOx crystals may also be required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821183     DOI: 10.1007/s00240-013-0584-5

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  40 in total

Review 1.  Chronic inflammation links cardiovascular, metabolic and renal diseases.

Authors:  Ichiro Manabe
Journal:  Circ J       Date:  2011-11-08       Impact factor: 2.993

2.  Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice.

Authors:  Robert W Freel; Marguerite Hatch; Mike Green; Manoocher Soleimani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-22       Impact factor: 4.052

3.  The function of oxalic acid in the human metabolism.

Authors:  Daniel Stewart Robertson
Journal:  Clin Chem Lab Med       Date:  2011-06-01       Impact factor: 3.694

Review 4.  Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2012-01-04

Review 5.  Mitochondria and cardiovascular aging.

Authors:  Dao-Fu Dai; Peter S Rabinovitch; Zoltan Ungvari
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

6.  Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.

Authors:  Naim M Maalouf; Prasanthi Tondapu; Eve S Guth; Edward H Livingston; Khashayar Sakhaee
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450

7.  Sequential studies of oxalate dynamics in primary hyperoxaluria.

Authors:  R W Watts; N Veall; P Purkiss
Journal:  Clin Sci (Lond)       Date:  1983-12       Impact factor: 6.124

8.  Effect of formate and oxalate on fluid reabsorption from the proximal convoluted tubule of the anaesthetized rat.

Authors:  M Wareing; R Green
Journal:  J Physiol       Date:  1994-06-01       Impact factor: 5.182

9.  Oxalosis and primary hyperoxaluria.

Authors:  E F SCOWEN; A G STANSFELD; R E WATTS
Journal:  J Pathol Bacteriol       Date:  1959-01

10.  Prevalence of hyperoxaluria after bariatric surgery.

Authors:  Bhavin N Patel; Corey M Passman; Adolfo Fernandez; John R Asplin; Fredric L Coe; Sam C Kim; James E Lingeman; Dean G Assimos
Journal:  J Urol       Date:  2008-11-14       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.